Search

Search Constraints

You searched for: Author/Creator Meyer, Kirstin

Search Results

1. BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling‐dependent tumor growth in mouse models. Issue 2 (20th October 2016)

2. Bile canaliculi remodeling activates YAP via the actin cytoskeleton during liver regeneration. Issue 2 (24th February 2020)

3. Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer. (16th October 2017)

4. Natural variability or anthropogenically-induced variation? Insights from 15 years of multidisciplinary observations at the arctic marine LTER site HAUSGARTEN. (June 2016)